Steptoe Therapeutics, Inc. is categorized under Wholesale Pharmaceutical Products in Hingham, MA and active since 2009.
Steptoe Therapeutics, Inc. was established in 2009, and today employs 1 to 4, earning Unknown per year. This is a Wholesale Pharmaceutical Products business, which does work in the B2B market, and is classified as a Wholesale Pharmaceutical Products, under code number by the NAICS.
If you are seeking more information, feel free to contact Eduardo Kelly at the company’s single location by writing to 10 Keith Way, Suite 3, Hingham, Massachusetts MA 02043 or by phoning (781) 556-5012. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Steptoe Therapeutics, Inc. |
| Contact Person: | Eduardo Kelly |
| Address: | 10 Keith Way, Suite 3, Hingham, Massachusetts 02043 |
| Phone Number: | (781) 556-5012 |
| Website Address: | steptoetherapeutics.com |
| Annual Revenue (USD): | Unknown |
| Founded: | 2009 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Wholesale Pharmaceutical Products |
| Share This Business: |
Steptoe Therapeutics, Inc. was started in 2009 to provide professional Wholesale Pharmaceutical Products under the SIC code and NAICS code . Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Eduardo Kelly for inquiries that concern Steptoe Therapeutics, Inc. by calling the company number (781) 556-5012, as your correspondence is most welcome. Additionally, the physical location of the single location of Steptoe Therapeutics, Inc. can be found at the coordinates 42.176492884755,-70.905 as well as the street address 10 Keith Way, Suite 3 in Hingham, Massachusetts 02043.
For its online presence, you may visit Steptoe Therapeutics, Inc.’s website at steptoetherapeutics.com and engage with its social media outlets through on Twitter and on Facebook.